Procaps Group S.A. ( PROCF) - Stock Earnings
PROCF Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q1 | 5.5 million USD | 84.2 million USD |
| 2023Q2 | 6.2 million USD | 110.1 million USD |
| 2023Q3 | 10.1 million USD | 118.4 million USD |
PROCF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2020 | — USD | 331.5 million USD |
| 2021 | -8.5 million USD | 409.7 million USD |
| 2022 | 73.6 million USD | 409.9 million USD |
| 2024 Est. | — | — |
PROCF
Price: $0.03
52 week price:
Earnings Per Share: 0.40 USD
P/E Ratio: 0.06
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 58.4 million